Leisa Renwick was presented The Herald New Zealander of the Year yesterday. Photo/John Borren
Leisa Renwick was moved to tears as her employer spoke of her courageous fight with cancer.
She was diagnosed with stage four melanoma on Mother's Day, 2015. At the time she was told there was nothing doctors could do and sent her home to die.
The mother of three would not accept the death sentence, and today because of her actions more people will live too.
She was awarded The Herald New Zealander of the Year award yesterday at Mount Maunganui College by Tauranga MP Simon Bridges after principal Russell Gordon shared a moving tribute to the brave woman.
Mr Gordon said he clearly remembered the day he was phoned on May 29, 2015 from another teacher at his school.
"That call rocked my world. I was told in that conversation Leisa Renwick was in hospital, it was unlikely she would leave and they expected her to pass away that weekend.
"You hear that and how do you respond?" he said.
Later that day, he got a call from the same teacher and he thought to himself, "I don't want to answer that" but he did.
"Mrs Renwick was given hours to live and her family was there by her side."
Since that prediction, Mrs Renwick had rewritten the rules.
"In fact that rule book has been ripped up and she has written her own. She sits here today as a survivor which in itself is meritorious. But she also sits here as someone who almost single handedly took on a crown entity, Pharmac, and won.
"Pharmac decides which medicines and pharmaceutical products are subsidies so hospitals and communities can access them. Her fight to have Keytruda be made available to all, not just those who can afford it, is what we celebrate here this morning.
"Because of that fight there are people living today that would not otherwise. Because of that fight there are people in the future who will live and be able to spend more time with their families, loved ones because of what she has done.
"Ms Renwick sits here today as a champion because of her will to live which defies comprehension. She sits here as a hero."
In the presentation, Mrs Renwick inspired her students.
"We live in a living democracy, and that means a lot more than voting every three years. A democracy means we hold our representatives accountable all the time, every day.
"What I saw, when I saw people dying because they couldn't get access to medication that they could get in Australia, I thought that was wrong. It was a matter of standing up and saying that."
May 2015: Diagnosed with stage four melanoma and given weeks to live. Told no treatment available in public system. Started taking Dabrafenib, a gene therapy drug, which costs $12,000 a month.
August: Tests showed her cancer had shrunk. But she was told the cancer would become resistant to Dabrafenib.
October: She switched to Pembrolizumab, better known as Keytruda, which costs $8500 every three weeks.
November: Interviewed in Herald series on funding for cancer treatment. Appalled by "have, have not" divide in health care.
"It seems to me in this country the rich people are able to get treatment and the poor people aren't. They are sent home with lots of painkilling drugs. They are sent home to die. I think that's really wrong."
Starts petition to Parliament requesting more funding for Pharmac to provide Pembrolizumab for those with advanced melanoma.
March 2016: Presents petition of 11,085 signatures on steps of Parliament.
May: Government announces $39 million funding boost for Pharmac.
June: Pharmac announces Keytruda will be publicly funded from September.
August: Renwick makes submission on petition to Health Select Committee, unusual because the petition was already successful.